Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
TB Alliance
TB Alliance
Activities:
Research & Development
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Drug Delivery
World's first child-friendly TB medicines in correct doses
The new fixed-dose formulations for children will offer hope for the 400 children who needlessly die of TB each day
Research & Development
Novartis supplies tuberculosis drug candidates to TB Alliance
Included are drugs called indolcarboxamides that are active against drug sensitive and multi-resistant strains of TB
Research & Development
Sanofi and TB Alliance to accelerate TB drug development
Research collaboration will focus on optimising and developing compounds in the Sanofi library
Research & Development
South African trial milestone signals TB drug breakthrough
Combination of three drugs able to kill TB bacteria within two weeks
Research & Development
China to establish international r&d centre for global health
Partnership joins public and private sectors to develop new treatments for TB, malaria and HIV/AIDS
Research & Development
TB Alliance and AstraZeneca to fight tuberculosis
Agree to new research to speed up development of TB drugs
Subscribe now